289 related articles for article (PubMed ID: 11840149)
1. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome.
Fleitz J; Rumelhart S; Goldman F; Ambruso D; Sokol RJ; Pacini D; Quinones R; Holida M; Lee N; Tannous R; Giller R
Bone Marrow Transplant; 2002 Jan; 29(1):75-9. PubMed ID: 11840149
[TBL] [Abstract][Full Text] [Related]
2. Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome.
Vibhakar R; Radhi M; Rumelhart S; Tatman D; Goldman F
Bone Marrow Transplant; 2005 Nov; 36(10):855-61. PubMed ID: 16113664
[TBL] [Abstract][Full Text] [Related]
3. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.
Sauer M; Zeidler C; Meissner B; Rehe K; Hanke A; Welte K; Lohse P; Sykora KW
Bone Marrow Transplant; 2007 Feb; 39(3):143-7. PubMed ID: 17211437
[TBL] [Abstract][Full Text] [Related]
4. Successful unrelated bone marrow transplantation for Shwachman-Diamond syndrome.
Cesaro S; Guariso G; Calore E; Gazzola MV; Destro R; Varotto S; Zanesco L; Messina C
Bone Marrow Transplant; 2001 Jan; 27(1):97-9. PubMed ID: 11244445
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
[TBL] [Abstract][Full Text] [Related]
6. Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation.
Cesaro S; Oneto R; Messina C; Gibson BE; Buzyn A; Steward C; Gluckman E; Bredius R; Boogaerts M; Vermylen C; Veys P; Marsh J; Badell I; Michel G; Güngör T; Niethammer D; Bordigoni P; Oswald C; Favre C; Passweg J; Dini G;
Br J Haematol; 2005 Oct; 131(2):231-6. PubMed ID: 16197455
[TBL] [Abstract][Full Text] [Related]
7. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation in Shwachman-Diamond syndrome.
Hsu JW; Vogelsang G; Jones RJ; Brodsky RA
Bone Marrow Transplant; 2002 Aug; 30(4):255-8. PubMed ID: 12203143
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
10. First experience of hematopoietic stem cell transplantation treatment of Shwachman-Diamond syndrome using unaffected HLA-matched sibling donor produced through preimplantation HLA typing.
Isaev AA; Deev RV; Kuliev A; Plaxa IL; Stancheva NV; Borovkova AS; Potapov IV; Pomerantseva EA; Chogovadze AG; Boyarsky KY; Semenenko AE; Mikhailov AV; Shevchenko KG; Prikhodko AV; Rechitsky S; Paina OV; Barchatov IM; Zubarovskaya LS; Verlinsky O; Bozo IY; Afanasyev BV
Bone Marrow Transplant; 2017 Sep; 52(9):1249-1252. PubMed ID: 28346418
[TBL] [Abstract][Full Text] [Related]
11. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
12. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
Bailey HK; Kappy MS; Giller RH; Gralla J
Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
[TBL] [Abstract][Full Text] [Related]
13. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome.
Bhatla D; Davies SM; Shenoy S; Harris RE; Crockett M; Shoultz L; Smolarek T; Bleesing J; Hansen M; Jodele S; Jordan M; Filipovich AH; Mehta PA
Bone Marrow Transplant; 2008 Aug; 42(3):159-65. PubMed ID: 18500373
[TBL] [Abstract][Full Text] [Related]
14. Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis.
Cesaro S; Gazzola MV; Marson P; Calore E; Caenazzo L; Destro R; De Silvestro G; Varotto S; Pillon M; Zanesco L; Messina C
Am J Hematol; 2003 Feb; 72(2):143-6. PubMed ID: 12555220
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience.
Tomizawa D; Imai K; Ito S; Kajiwara M; Minegishi Y; Nagasawa M; Morio T; Nonoyama S; Mizutani S
Am J Hematol; 2004 May; 76(1):33-9. PubMed ID: 15114594
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register.
Ferry C; Ouachée M; Leblanc T; Michel G; Notz-Carrére A; Tabrizi R; Flood T; Lutz P; Fischer A; Gluckman E; Donadieu J
Bone Marrow Transplant; 2005 Jan; 35(1):45-50. PubMed ID: 15489867
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]